Bruush Oral Care Stock Price To Earnings To Growth
| BRSHDelisted Stock | USD 0.0005 0.0001 16.67% |
Bruush Oral Care fundamentals help investors to digest information that contributes to Bruush Oral's financial success or failures. It also enables traders to predict the movement of Bruush Stock. The fundamental analysis module provides a way to measure Bruush Oral's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bruush Oral stock.
Bruush |
Bruush Oral Care Company Price To Earnings To Growth Analysis
Bruush Oral's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Bruush Oral Care has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Personal Care Products sector and 100.0% lower than that of the Consumer Staples industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Bruush Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bruush Oral's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bruush Oral could also be used in its relative valuation, which is a method of valuing Bruush Oral by comparing valuation metrics of similar companies.Bruush Oral is currently under evaluation in price to earnings to growth category among its peers.
Bruush Fundamentals
| Return On Asset | -5.77 | |||
| Profit Margin | (2.57) % | |||
| Operating Margin | (5.29) % | |||
| Current Valuation | 2.51 M | |||
| Shares Outstanding | 100.97 M | |||
| Shares Owned By Insiders | 17.35 % | |||
| Shares Owned By Institutions | 12.96 % | |||
| Number Of Shares Shorted | 2.22 M | |||
| Price To Sales | 2.97 X | |||
| Revenue | 2.63 M | |||
| Gross Profit | 1.76 M | |||
| EBITDA | (10.49 M) | |||
| Net Income | (8.77 M) | |||
| Total Debt | 2.59 M | |||
| Current Ratio | 0.21 X | |||
| Book Value Per Share | (10.12) X | |||
| Cash Flow From Operations | (12.59 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | (14.67) X | |||
| Number Of Employees | 11 | |||
| Market Capitalization | 8.68 M | |||
| Total Asset | 1.19 M | |||
| Retained Earnings | (26.39 M) | |||
| Working Capital | (1.41 M) | |||
| Net Asset | 1.19 M |
About Bruush Oral Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bruush Oral Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bruush Oral using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bruush Oral Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Bruush Stock
If you are still planning to invest in Bruush Oral Care check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bruush Oral's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |